ReleaseWire Connect

An investigation on behalf of investors, who currently hold shares of Kinder Morgan Energy Partners LP (NYSE:KMP), was announced concerning whether the takeover of Kinder Morgan Energy Partners LP by Kinder Morgan, Inc. for a value of $89.98 per KMP unit is unfair to NYSE:KMP stockholders.

An investigation on behalf of investors, who currently hold shares of Intervest Bancshares Corp (NASDAQ:IBCA), was announced concerning whether the takeover of Intervest Bancshares Corp by Bank Of The Ozarks Inc is unfair to NASDAQ:IBCA stockholders.

An investigation on behalf of current long-term investors in shares Genworth Financial Inc (NYSE:GNW) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Genworth Financial Inc.

An investigation on behalf of investors, who currently hold shares of Fortegra Financial Corp (NYSE:FRF), was announced concerning whether the takeover of Fortegra Financial Corp. by Tiptree Financial Inc is unfair to NYSE:FRF stockholders.

An investor, who currently holds shares of Journal Communications, Inc. (NYSE:JRN) filed a lawsuit in effort to halt the proposed takeover of Journal Communications by E.W. Scripps Co.

An investigation on behalf of current long-term investors in shares of Provectus Pharmaceuticals Inc (NYSEMKT:PVCT) concerning potential breaches of fiduciary duties by certain directors and officers of Provectus Pharmaceuticals was announced.

An investigation on behalf of investors of Biota Pharmaceuticals Inc (NASDAQ:BOTA) shares over potential securities laws violations by Biota Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors, who currently hold shares of El Paso Pipeline Partners, L.P.(NYSE:EPB), was announced concerning whether the takeover of El Paso Pipeline Partners, L.P. by Kinder Morgan, Inc for a value of $38.79 per unit is unfair to NYSE:EPB stockholders.

An investigation on behalf of investors in shares of Blyth, Inc. (NYSE:BTH) shares was initiated concerning potential violations of Federal Securities Laws by Blyth, Inc.

An investigation on behalf of current long-term investors in shares Osiris Therapeutics, Inc. (NASDAQ:OSIR) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Osiris Therapeutics, Inc.